Beyer-Westendorf J - Search Results

1

The CHA₂DS₂-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease.

Beyer-Westendorf J, Kreutz R, Posch F, Ay C. Beyer-Westendorf J, et al. Int J Cardiol. 2018 Feb 15;253:71-77. doi: 10.1016/j.ijcard.2017.10.110. Int J Cardiol. 2018. PMID: 29306476

2

Drug persistence with rivaroxaban therapy in atrial fibrillation patients-results from the Dresden non-interventional oral anticoagulation registry.

Beyer-Westendorf J, Förster K, Ebertz F, Gelbricht V, Schreier T, Göbelt M, Michalski F, Endig H, Sahin K, Tittl L, Weiss N. Beyer-Westendorf J, et al. Europace. 2015 Apr;17(4):530-8. doi: 10.1093/europace/euu319. Epub 2015 Feb 17. Europace. 2015. PMID: 25694537 Free PMC article.

3

Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation.

Beyer-Westendorf J, Ehlken B, Evers T. Beyer-Westendorf J, et al. Europace. 2016 Aug;18(8):1150-7. doi: 10.1093/europace/euv421. Epub 2016 Jan 31. Europace. 2016. PMID: 26830891

4

Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting.

Beyer-Westendorf J, Michalski F, Tittl L, Middeldorp S, Cohen H, Abdul Kadir R, Arachchillage DJ, Arya R, Ay C, Marten S. Beyer-Westendorf J, et al. Thromb Haemost. 2016 Sep 27;116(4):651-8. doi: 10.1160/TH16-04-0305. Epub 2016 Jul 7. Thromb Haemost. 2016. PMID: 27384740

5

Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.

Becattini C, Franco L, Beyer-Westendorf J, Masotti L, Nitti C, Vanni S, Manina G, Cattinelli S, Cappelli R, Sbrojavacca R, Pomero F, Marten S, Agnelli G. Becattini C, et al. Int J Cardiol. 2017 Jan 15;227:261-266. doi: 10.1016/j.ijcard.2016.11.117. Epub 2016 Nov 9. Int J Cardiol. 2017. PMID: 27843050

6

Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry.

Keller L, Marten S, Hecker J, Sahin K, Tittl L, Beyer-Westendorf J. Keller L, et al. Int J Cardiol. 2018 Apr 15;257:276-282. doi: 10.1016/j.ijcard.2017.10.097. Int J Cardiol. 2018. PMID: 29506708

7

Impact of BMI on clinical outcomes of NOAC therapy in daily care - Results of the prospective Dresden NOAC Registry (NCT01588119).

Tittl L, Endig S, Marten S, Reitter A, Beyer-Westendorf I, Beyer-Westendorf J. Tittl L, et al. Int J Cardiol. 2018 Jul 1;262:85-91. doi: 10.1016/j.ijcard.2018.03.060. Epub 2018 Mar 14. Int J Cardiol. 2018. PMID: 29622509 Clinical Trial.

8

Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.

Riess H, Ay C, Bauersachs R, Becattini C, Beyer-Westendorf J, Cajfinger F, Chau I, Cohen AT, Khorana AA, Maraveyas A, Renni M, Young AM. Riess H, et al. Oncologist. 2018 Jul;23(7):822-839. doi: 10.1634/theoncologist.2017-0473. Epub 2018 Apr 12. Oncologist. 2018. PMID: 29650686 Free PMC article. Review.

9

Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease.

Posch F, Ay C, Stöger H, Kreutz R, Beyer-Westendorf J. Posch F, et al. Int J Cardiol. 2019 May 1;282:47-52. doi: 10.1016/j.ijcard.2019.01.089. Epub 2019 Jan 27. Int J Cardiol. 2019. PMID: 30777405

10

Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants.

Ay C, Beyer-Westendorf J, Pabinger I. Ay C, et al. Ann Oncol. 2019 Jun 1;30(6):897-907. doi: 10.1093/annonc/mdz111. Ann Oncol. 2019. PMID: 30918939 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters